Acts within the intestine, with minimal systemic absorption
Short, meal-matched insulin release
Manufactured at a WHO-GMP certified facility under GLP and ISO norms
Every batch quality tested in-house before dispatch
Indications of Gluvog-Rapid 0.3/1
Type 2 diabetes mellitus
Type 2 diabetes inadequately controlled on diet and exercise
Type 2 diabetes inadequately controlled on single-agent therapy
Postprandial hyperglycaemia
How Gluvog-Rapid 0.3/1 works
Voglibose 0.3 mg + Repaglinide 1mg SR - Gluvog Rapid 0.3/1 is part of Cista Medicorp's Anti Diabetic range. Detailed mechanism of action and clinical information is available on request from our medical team.
Why ChooseGluvog-Rapid 0.3/1?
Manufactured at a WHO-GMP certified facility under GLP, ISO and GMP norms, with raw material from approved vendors and in-house quality testing on every batch. Offered to PCD franchise partners on district-wise monopoly rights, with pan-India supply and complete promotional support.
Frequently asked questions about Gluvog-Rapid 0.3/1
Is monopoly available for this product?
Yes. District-wise monopoly rights are offered across India. Tell us your district and we will confirm availability.
What is the composition of Gluvog-Rapid 0.3/1?
Voglibose 0.3 mg + Repaglinide 1mg SR.
Is this manufactured at a WHO-GMP certified facility?
Yes. Manufacturing follows GLP, WHO, ISO and GMP norms, and every batch is quality tested in-house before dispatch.
What is the minimum order quantity?
Please contact our team for the current MOQ and price structure for your territory.
Last updated on 29 August 2026
This information is for reference only and is not a substitute for advice from a qualified doctor or pharmacist. Please consult your physician before use.
Cista Medicorp
